Tioga Pharmaceuticals, Inc.
Industry
- Biotechnology
- Medical Devices
- Surgical Equipment & Devices
- Minimally or Less Invasive
- Implantable Devices
- Surgical Equipment & Devices
- Pharmaceuticals
Latest on Tioga Pharmaceuticals, Inc.
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
Clinical trials for irritable bowel syndrome treatments should be designed to demonstrate not just short-term benefit but also efficacy in maintenance and retreatment, FDA said in a recently finalized
IN VITRO DIAGNOSTICS Abingdon Health Ltd. Abingdon Health brings in £3mm through an early-stage venture round Abingdon Health Ltd. (diagnostics) has raised £3mm ($4.8mm) through an early-stage
Ocera Therapeutics' spherical carbon adsorbent Zysa for the treatment of diarrhoea-predominant irritable bowel syndrome (D-IBS) is on two different paths in the US and in the EU, where the oral produc